Skip to main content
. 2019 Jun 12;14(6):e0217572. doi: 10.1371/journal.pone.0217572

Fig 2. The change in lymphocyte levels 30 days after MSC therapy.

Fig 2

Samples were taken from GvHD patients prior to MSC therapy and 30 days after therapy; blood count and differential count were examined. The change in responder patients appears on the left (p = 0.037) and among non-responder patients on the right (p = 0.74).